Embree Financial Group Bristol Myers Squibb CO Transaction History
Embree Financial Group
- $510 Billion
- Q1 2024
A detailed history of Embree Financial Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Embree Financial Group holds 9,969 shares of BMY stock, worth $451,296. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,969
Previous 10,158
1.86%
Holding current value
$451,296
Previous $521 Million
3.72%
% of portfolio
0.11%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,482Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$8.42 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.36 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.15 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.02 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.18 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...